{
  "symbol": "ACIU",
  "company": "AC Immune SA",
  "generated_at": "2026-06-24T07:36:44.218Z",
  "event_count": 1,
  "events": [
    {
      "type": "scout_dossier",
      "ts": "2026-06-15T11:11:12.535Z",
      "summary": "The investigation confirmed 4 Form 4 filings within the trigger window (June 11), but all were RSU/option grants (equity compensation at $0 cost basis) — not open-market purchases. The CEO's sole genuine P-code purchase ($31,425 on April 15 at $3.14) was effectively unwound by her sale of equivalent shares a month later at ~$2.79. No director made an open-market equity investment. AC Immune is a pre-revenue Swiss biotech burning cash with no commercial products; the stock sits near its 52-week low, down 35% YTD against a -34.75% period return. The primary bull catalyst — ABATE Phase 1b/2 data for ACI-24 in Alzheimer's — is expected Q2 2026 (data read still pending at time of investigation), but the CEO transition from Dr. Andrea Pfeifer to interim Chair Martin Zügel introduces operational uncertainty precisely when a key inflection point approaches.",
      "verdict": "no_anomaly",
      "confidence": 4,
      "tool_calls": 26,
      "walltime_min": 8,
      "debug_path": "dossiers/2026-06-15-ACIU.scout.debug.json"
    }
  ],
  "lessons": [],
  "chart_signal": {
    "ticker": "ACIU",
    "call": "HOLD",
    "confidence": 2,
    "score": -1,
    "factors": {
      "below_200dma": "-2",
      "below_50dma": "-1",
      "momentum_strong_up": "+2 (35.4%)",
      "rsi_neutral": "0 (46.7)",
      "macd_above_signal": "+1",
      "recent_macd_bullish_cross": "+1 (3d ago)",
      "broken_below_high": "-2 (-38.6% from high)"
    },
    "summary": "HOLD (score -1) · 12-1 mom 35.4% · RSI 46.7 · below_both · -38.6% from high",
    "last_close": 2.45,
    "one_month_ago_close": 2.85,
    "twelve_month_ago_close": 2.11,
    "twelve_one_momentum_pct": 35.39,
    "rsi_14": 46.7,
    "ma_stack": "below_both",
    "from_period_high_pct": -38.6,
    "period_high": 3.99,
    "price_targets": {
      "bear": 2.79,
      "fair": 4.62,
      "bull": 11.52,
      "bear_return_pct": 14,
      "fair_return_pct": 88.5,
      "bull_return_pct": 370.3,
      "method": "street_targets ⨯ chart_floors",
      "street": {
        "target_low": 6.7661486,
        "target_mean": 8.662543,
        "target_high": 11.522537,
        "analyst_count": 4
      }
    },
    "generated_at": "2026-06-24T07:36:44.214Z"
  }
}